WGS

GeneDx Holdings Corp. · Healthcare · Market cap $2.1B

Insiders sold $1.8M net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 18, 2026

Insider Buying

$106.6M

reported purchases (SEC code P)

Insider Selling

$21.8M

reported sales (SEC code S)

Unique Insiders

6

in the rolling window

Latest filing

Sep 18, 2026

Stueland Katherine

GeneDx Holdings Corp. (WGS) has 47 SEC Form 4 filings (184 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Sep 18, 2026.

Inside the rolling window, 6 insiders at GeneDx Holdings Corp. reported 13 open-market purchases totaling $106.6M and 33 open-market sales totaling $21.8M. The most active filer is CHIEF FINANCIAL OFFICER Feeley Kevin with 17 filings. Insiders have net bought $86.5M over the trailing 6 months. The largest single insider purchase in this window was $20.2M by Director, 10% Owner Meister Keith A. on May 7, 2026. The most recent open-market filing is a sale of 10,501 shares by CHIEF EXECUTIVE OFFICER Stueland Katherine, dated Sep 16, 2026, worth $1.0M.

  • Industry:Medical - Diagnostics & Research
  • CEO:Katherine A. Stueland
  • Employees:1,300
  • HQ:Stamford, CT, US
  • IPO:2020-11-04
Source
Sale$1.0MSep 18SEC ↗
Sale$364KSep 18SEC ↗
Sale$108KSep 11SEC ↗
Sale$311KSep 11SEC ↗
Sale$31KSep 3SEC ↗
Sale$227KJun 18SEC ↗
Sale$638KJun 18SEC ↗
Sale$196KJun 11SEC ↗
Sale$68KJun 11SEC ↗
Purchase$8.5MJun 8SEC ↗
Purchase$2.6MJun 8SEC ↗
Sale$19KJun 3SEC ↗
Purchase$7.4MMay 20SEC ↗
Purchase$7.9MMay 20SEC ↗
Purchase$6.1MMay 20SEC ↗
Purchase$6.4MMay 15SEC ↗
Purchase$5.5MMay 15SEC ↗
Purchase$1.8MMay 15SEC ↗
Purchase$20.2MMay 12SEC ↗
Purchase$7.0MMay 12SEC ↗
Purchase$19.6MMay 12SEC ↗
Sale$26KMay 1SEC ↗
Sale$142KMay 1SEC ↗
Sale$3.0MMar 30SEC ↗
Sale$557KMar 30SEC ↗
Showing 1–25 of 46
1 / 2

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does WGS have?

GeneDx Holdings Corp. (WGS) has 47 SEC Form 4 filings (184 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Sep 18, 2026.

When was the most recent SEC Form 4 filing for WGS?

The most recent Form 4 filing for WGS on Tracefour is dated Sep 18, 2026.

Who is the most active insider at WGS?

The most active SEC Form 4 filer at WGS in the rolling window is CHIEF FINANCIAL OFFICER Feeley Kevin, with 17 filings.

What is the net insider flow at WGS over the last 6 months?

Over the trailing 180 days, insiders at WGS have net bought $86.5M based on SEC Form 4 disclosures.

What was the largest insider purchase at WGS?

The largest single insider open-market purchase at WGS in the rolling window was $20.2M by Director, 10% Owner Meister Keith A. on 2026-05-07.

What is the total insider buy and sell value at WGS in the current window?

Inside the rolling window, insiders at WGS bought $106.6M and sold $21.8M based on SEC Form 4 filings.

Can I get alerts for WGS insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at GeneDx Holdings Corp. (WGS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

GeneDx Holdings Corp. is in the Healthcare sector.